Inhibitor Therapeutics, Inc. Cash and Cash Equivalents
Inhibitor Therapeutics, Inc. (INTI) had Cash and Cash Equivalents of $515.76 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $515.76K.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $1.29M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $2.38M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $2.98M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $515.76K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.38M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $2.98M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.74M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.32M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $5.61M 10-K · filed 2026-03-26 |
| 2024-09-30 | $6.38M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $7.10M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $7.68M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $8.84M 10-K · filed 2025-03-28 |
| 2023-09-30 | $9.54M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $10.10M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $10.78M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.95M 10-K · filed 2024-03-29 |
| 2022-09-30 | $53.06K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $24.95K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $36.44K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $30.63K 10-K · filed 2023-03-31 |
| 2021-09-30 | $53.29K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $93.72K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $84.19K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $75.06K 10-K · filed 2022-03-30 |
| 2020-09-30 | $36.71K 10-Q · filed 2021-11-12 |
| 2020-06-30 | $137.32K 10-Q · filed 2021-08-13 |
| 2020-03-31 | $302.69K 10-Q · filed 2021-05-14 |
| 2019-12-31 | $803.82K 10-K · filed 2022-03-30 |
| 2019-09-30 | $1.37M 10-Q · filed 2020-11-16 |
| 2019-06-30 | $2.03M 10-Q · filed 2020-08-12 |
| 2019-03-31 | $1.13M 10-Q · filed 2020-05-01 |
| 2018-12-31 | $1.11M 10-K · filed 2021-03-26 |
| 2018-09-30 | $1.44M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $795.76K 10-Q · filed 2019-08-12 |
| 2018-03-31 | $1.57M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $344.11K 10-K · filed 2020-03-30 |
| 2017-09-30 | $887.36K 10-Q · filed 2018-11-14 |
| 2017-06-30 | $1.64M 10-Q · filed 2018-07-23 |
| 2017-03-31 | $2.34M 10-Q · filed 2018-05-01 |
| 2016-12-31 | $6.89M 10-K · filed 2019-03-07 |
| 2016-09-30 | $3.55M 10-Q · filed 2017-10-31 |
| 2016-06-30 | $4.62M 10-Q · filed 2017-07-31 |
| 2016-03-31 | $118.62K 10-Q · filed 2017-05-08 |
| 2015-12-31 | $601.45K 10-K · filed 2018-02-16 |
| 2015-09-30 | $1.24M 10-Q · filed 2016-10-31 |
| 2015-06-30 | $1.89M 10-Q · filed 2016-08-12 |
| 2015-03-31 | $83.95K 10-Q · filed 2016-05-13 |
| 2014-12-31 | $365.16K 10-K · filed 2017-02-17 |
| 2014-09-30 | $375.87K 10-Q · filed 2015-11-04 |
| 2014-06-30 | $271.23K 10-Q · filed 2015-08-14 |
| 2014-03-31 | $456.00 10-Q · filed 2015-05-13 |
| 2013-12-31 | $217.00 10-K · filed 2016-02-01 |
| 2013-09-30 | $112.00 10-Q · filed 2014-10-10 |
| 2013-06-30 | $1.11K 10-Q · filed 2014-08-13 |
| 2013-03-31 | $776.47K 10-Q · filed 2014-05-12 |
| 2013-01-04 | $857.70K 10-Q · filed 2014-10-10 |
| 2012-12-31 | $857.70K 10-K · filed 2015-02-13 |
| 2012-09-30 | $923.42K 10-Q · filed 2013-11-14 |
| 2011-12-31 | $1.32M 10-K · filed 2014-04-15 |